Literature DB >> 33434361

FoxM1 promotes Wnt/β-catenin pathway activation and renal fibrosis via transcriptionally regulating multi-Wnts expressions.

Hongyan Xie1, Naijun Miao1, Dan Xu1, Zhuanli Zhou1, Jiayun Ni1, Fan Yin1, Yanzhe Wang2, Qian Cheng1, Panpan Chen1, Jingyao Li1, Peiqing Zheng1, Li Zhou1, Jun Liu1, Wei Zhang1, Xiaoxia Wang2, Limin Lu1,3.   

Abstract

The activation of Wnt/β-catenin pathway plays a pivotal role in promoting renal fibrosis. The activation of Wnt/β-catenin pathway relies on the binding of Wnts to Frizzled receptors on cell membrane. However, the factor regulating Wnts production remains unclear. Here, we demonstrated that transcriptional factor FoxM1 was significantly increased in obstructed kidneys and patients' kidneys with fibrosis. The up-regulation of FoxM1 mainly distributed in tubular epithelial cells. Pharmacological inhibition of FoxM1 down-regulated multi-Wnts elevation in UUO mice and attenuated renal fibrosis. In cultured renal tubular epithelial cells, overexpression of FoxM1 promoted 8 Wnts expression, while knock-down on FoxM1-suppressed multi-Wnts including Wnt1, Wnt2b and Wnt3 expression induced by Ang II. Chromatin immunoprecipitation PCR confirmed that FoxM1 bound to Wnt1, Wnt2b, Wnt3 promoters and luciferase assay further identified that the transcriptions of Wnt1, Wnt2b and Wnt3 were regulated by FoxM1. Thus, our findings show that multi-Wnt family members were regulated by transcriptional factor FoxM1. FoxM1 might be a key switch for activating β-catenin pathway and renal fibrosis. Therefore, FoxM1 might be a potential therapeutic target in manipulating renal fibrosis.
© 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  FoxM1; Wnts; renal fibrosis; β-catenin

Year:  2021        PMID: 33434361     DOI: 10.1111/jcmm.15948

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  3 in total

1.  MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3.

Authors:  Wei Liu; Dexin Shen; Lingao Ju; Renjie Zhang; Wenzhi Du; Wan Jin; Kangping Xiong; Gang Wang; Kaiyu Qian; Yi Zhang; Yu Xiao; Xinghuan Wang
Journal:  Oncogene       Date:  2022-09-07       Impact factor: 8.756

2.  Forkhead Domain Inhibitor-6 Suppresses Corneal Neovascularization and Subsequent Fibrosis After Alkali Burn in Rats.

Authors:  Chunlin Lan; Guo Liu; Longxiang Huang; Xizhen Wang; Junkai Tan; Yun Wang; Ning Fan; Yihua Zhu; Man Yu; Xuyang Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-04-01       Impact factor: 4.925

3.  Integrated bioinformatical analysis, machine learning and in vitro experiment-identified m6A subtype, and predictive drug target signatures for diagnosing renal fibrosis.

Authors:  Chunxiang Feng; Zhixian Wang; Chang Liu; Shiliang Liu; Yuxi Wang; Yuanyuan Zeng; Qianqian Wang; Tianming Peng; Xiaoyong Pu; Jiumin Liu
Journal:  Front Pharmacol       Date:  2022-08-31       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.